Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000463486 | SCV000547770 | uncertain significance | Fanconi anemia | 2022-10-18 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 221 of the FANCA protein (p.Met221Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with pancreatic cancer (PMID: 15591268). ClinVar contains an entry for this variant (Variation ID: 408195). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FANCA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV000463486 | SCV002535066 | uncertain significance | Fanconi anemia | 2021-05-10 | criteria provided, single submitter | curation | |
Gene |
RCV002269275 | SCV002552695 | uncertain significance | not provided | 2022-01-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Observed in an individual with pancreatic cancer (Rogers 2004); This variant is associated with the following publications: (PMID: 15591268) |
Fulgent Genetics, |
RCV001274656 | SCV002778805 | uncertain significance | Fanconi anemia complementation group A | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274656 | SCV001459010 | uncertain significance | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing |